Skip to content
The Nexus
DossierENTITY

Dr. Natalie Azar

Coverage of Dr. Natalie Azar in the Nexus archive.

Earliest in view: May 21 · 12:04 UTCMost recent: May 21 · 12:04 UTC
Co-mentioned in this coverage
Eli Lillyorganization1retatrutidetopic1GLP-1topic1NBCorganization1FDAorganization1
Recent coverage
  • HEALTHMay 21 · 12:04 UTCNBC NEWS
    New Weight Loss Drug Retatrutide Delivers Stunning Results

    Eli Lilly's new weight loss drug retatrutide has shown remarkable trial results, potentially outperforming existing GLP-1 medications. The drug works by mimicking three hormones that regulate hunger and fat burning. NBC medical contributor Dr. Natalie Azar discusses the trial outcomes and FDA approval timeline.